• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Factor V inhibitor associated with cold agglutinin disease.

作者信息

van Spronsen D J, Oosting J D, Hoffmann J J, Breed W P

机构信息

Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.

出版信息

Ann Hematol. 1998 Jan;76(1):49-50. doi: 10.1007/s002770050361.

DOI:10.1007/s002770050361
PMID:9486926
Abstract

An 81-year-old man known to have a stable cold agglutinin syndrome presented with a progressive cerebral hemorrhage. Coagulation tests revealed prolonged APTT and prothrombin time and severely decreased factor V activity, which could not be normalized by mixing with normal plasma. The patient appeared refractory to substitution with fresh-frozen plasma, suggesting the presence of a circulating inhibitor specific for factor V. To our knowledge, this is the first case of a lymphoproliferative disease leading to a cold agglutinin syndrome and a putative inhibitor of factor V. In patients with paraproteinemia presenting with bleeding diathesis, the presence of a circulating inhibitor of a specific coagulation factor must be considered.

摘要

相似文献

1
Factor V inhibitor associated with cold agglutinin disease.
Ann Hematol. 1998 Jan;76(1):49-50. doi: 10.1007/s002770050361.
2
Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.获得性凝血因子V抑制剂与危及生命的出血相关,且混合试验结果提示凝血因子缺乏。
Hematology. 2013 Sep;18(5):300-4. doi: 10.1179/1607845412Y.0000000072. Epub 2013 May 15.
3
Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone.一名服用华法林的患者出现与获得性凝血因子V抑制剂相关的出血,使用泼尼松龙成功治疗。
BMJ Case Rep. 2013 Aug 6;2013:bcr2013010018. doi: 10.1136/bcr-2013-010018.
4
[Acquired inhibitor against coagulation factor V with severe hematuria].[获得性凝血因子V抑制物伴严重血尿]
Rinsho Ketsueki. 2003 Sep;44(9):933-9.
5
[A long-lasting idiopathic factor V inhibitor].[一种持续性特发性因子V抑制剂]
Rinsho Ketsueki. 2003 Jan;44(1):14-8.
6
[High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].[高滴度特发性获得性因子V抑制剂患者出现多种凝血因子活性降低]
Rinsho Ketsueki. 2008 Jun;49(6):413-6.
7
The response of an acquired Factor V inhibitor to activated Factor IX concentrate.获得性凝血因子V抑制剂对活化凝血因子IX浓缩物的反应。
Transfusion. 1985 Jan-Feb;25(1):51-3. doi: 10.1046/j.1537-2995.1985.25185116503.x.
8
A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.一种非常有效的因子 V 抑制剂会干扰所有凝血因子的水平,导致致命性出血综合征。
Eur J Haematol. 2019 Aug;103(2):137-139. doi: 10.1111/ejh.13249. Epub 2019 May 28.
9
Acquired Factor V Inhibitor.获得性凝血因子Ⅴ抑制剂
Intern Med. 2016;55(20):3039-3042. doi: 10.2169/internalmedicine.55.6459. Epub 2016 Oct 15.
10
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.危及生命的出血与原发性系统性淀粉样变性相关的获得性凝血因子V缺乏症。
Blood Coagul Fibrinolysis. 2002 Sep;13(6):555-9. doi: 10.1097/00001721-200209000-00011.

引用本文的文献

1
Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review.自身免疫性疾病患者中的抗凝血因子V抑制剂:病例报告及文献综述
Int Med Case Rep J. 2011 Apr 20;4:31-4. doi: 10.2147/IMCRJ.S19433. Print 2011.
2
Acquired factor V inhibitors: a systematic review.获得性因子 V 抑制剂:系统评价。
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.